These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

316 related items for PubMed ID: 19159953

  • 1. Risk factors for Kawasaki disease-associated coronary abnormalities differ depending on age.
    Song D, Yeo Y, Ha K, Jang G, Lee J, Lee K, Son C, Lee J.
    Eur J Pediatr; 2009 Nov; 168(11):1315-21. PubMed ID: 19159953
    [Abstract] [Full Text] [Related]

  • 2. Incomplete Kawasaki disease in patients younger than 1 year of age: a possible inherent risk factor.
    Yeo Y, Kim T, Ha K, Jang G, Lee J, Lee K, Son C, Lee J.
    Eur J Pediatr; 2009 Feb; 168(2):157-62. PubMed ID: 18478263
    [Abstract] [Full Text] [Related]

  • 3. Predictive risk factors for coronary artery abnormalities in Kawasaki disease.
    Kim T, Choi W, Woo CW, Choi B, Lee J, Lee K, Son C, Lee J.
    Eur J Pediatr; 2007 May; 166(5):421-5. PubMed ID: 17033807
    [Abstract] [Full Text] [Related]

  • 4. Japanese Kawasaki Disease Scoring Systems: Are they Applicable to the Iranian Population?
    Edraki MR, Mohammadi H, Mehdizadegan N, Ghorashi M, Amoozgar H, Borzouee M, Ajami G, Keshavarz K, Dehghani E, Bahrami R.
    Arch Iran Med; 2020 Jan 01; 23(1):31-36. PubMed ID: 31910632
    [Abstract] [Full Text] [Related]

  • 5. The Harada score in the US population of children with Kawasaki disease.
    Tewelde H, Yoon J, Van Ittersum W, Worley S, Preminger T, Goldfarb J.
    Hosp Pediatr; 2014 Jul 01; 4(4):233-8. PubMed ID: 24986993
    [Abstract] [Full Text] [Related]

  • 6. Risk factors for coronary artery abnormalities in children with Kawasaki disease: a 10-year experience.
    Maric LS, Knezovic I, Papic N, Mise B, Roglic S, Markovinovic L, Tesovic G.
    Rheumatol Int; 2015 Jun 01; 35(6):1053-8. PubMed ID: 25429794
    [Abstract] [Full Text] [Related]

  • 7. Kawasaki disease in Turkish children: a single center experience with emphasis on intravenous immunoglobulin resistance and giant coronary aneurysms.
    Yılmazer MM, Özdemir R, Meşe T, Küçük M, Öner T, Devrim İ, Bayram N, Güven B, Tavlı V.
    Turk J Pediatr; 2019 Jun 01; 61(5):648-656. PubMed ID: 32104995
    [Abstract] [Full Text] [Related]

  • 8. Increased Pentraxin 3 Levels Correlate With IVIG Responsiveness and Coronary Artery Aneurysm Formation in Kawasaki Disease.
    Kitoh T, Ohara T, Muto T, Okumura A, Baba R, Koizumi Y, Yamagishi Y, Mikamo H, Daigo K, Hamakubo T.
    Front Immunol; 2021 Jun 01; 12():624802. PubMed ID: 33912155
    [Abstract] [Full Text] [Related]

  • 9. Interleukin-6 is prone to be a candidate biomarker for predicting incomplete and IVIG nonresponsive Kawasaki disease rather than coronary artery aneurysm.
    Wu Y, Liu FF, Xu Y, Wang JJ, Samadli S, Wu YF, Liu HH, Chen WX, Luo HH, Zhang DD, Wei W, Hu P.
    Clin Exp Med; 2019 May 01; 19(2):173-181. PubMed ID: 30617865
    [Abstract] [Full Text] [Related]

  • 10. Risk of coronary artery lesions in young infants with Kawasaki disease: need for a new diagnostic method.
    Satoh K, Wakejima Y, Gau M, Kiguchi T, Matsuda N, Takasawa R, Takasawa K, Nishioka M, Shimohira M.
    Int J Rheum Dis; 2018 Mar 01; 21(3):746-754. PubMed ID: 29105337
    [Abstract] [Full Text] [Related]

  • 11. Association of Severity of Coronary Artery Aneurysms in Patients With Kawasaki Disease and Risk of Later Coronary Events.
    Miura M, Kobayashi T, Kaneko T, Ayusawa M, Fukazawa R, Fukushima N, Fuse S, Hamaoka K, Hirono K, Kato T, Mitani Y, Sato S, Shimoyama S, Shiono J, Suda K, Suzuki H, Maeda J, Waki K, The Z-score Project 2nd Stage Study Group, Kato H, Saji T, Yamagishi H, Ozeki A, Tomotsune M, Yoshida M, Akazawa Y, Aso K, Doi S, Fukasawa Y, Furuno K, Hayabuchi Y, Hayashi M, Honda T, Horita N, Ikeda K, Ishii M, Iwashima S, Kamada M, Kaneko M, Katyama H, Kawamura Y, Kitagawa A, Komori A, Kuraishi K, Masuda H, Matsuda S, Matsuzaki S, Mii S, Miyamoto T, Moritou Y, Motoki N, Nagumo K, Nakamura T, Nishihara E, Nomura Y, Ogata S, Ohashi H, Okumura K, Omori D, Sano T, Suganuma E, Takahashi T, Takatsuki S, Takeda A, Terai M, Toyono M, Watanabe K, Watanabe M, Yamamoto M, Yamamura K.
    JAMA Pediatr; 2018 May 07; 172(5):e180030. PubMed ID: 29507955
    [Abstract] [Full Text] [Related]

  • 12. Delayed intravenous immunoglobulin treatment increased the risk of coronary artery lesions in children with Kawasaki disease at different status.
    Qiu H, He Y, Rong X, Ren Y, Pan L, Chu M, Wu R, Shi H.
    Postgrad Med; 2018 May 07; 130(4):442-447. PubMed ID: 29745742
    [Abstract] [Full Text] [Related]

  • 13. Clinical relevance of the risk factors for coronary artery inflammation in Kawasaki disease.
    Honkanen VE, McCrindle BW, Laxer RM, Feldman BM, Schneider R, Silverman ED.
    Pediatr Cardiol; 2003 May 07; 24(2):122-6. PubMed ID: 12457252
    [Abstract] [Full Text] [Related]

  • 14. Identifying Kawasaki Disease With a Low Coronary Artery Aneurysm Risk.
    Iio K, Morikawa Y, Miyata K, Kaneko T, Misawa M, Yamagishi H, Miura M.
    Pediatr Infect Dis J; 2023 Jul 01; 42(7):608-613. PubMed ID: 37053581
    [Abstract] [Full Text] [Related]

  • 15. Blood routine risk factors for coronary artery aneurysm in infants younger than 8 months with Kawasaki disease.
    Haiyan G, Jianming L, Suqian T, Dong Q, Shuang L, Jin Z.
    BMC Pediatr; 2022 Jan 07; 22(1):29. PubMed ID: 34996405
    [Abstract] [Full Text] [Related]

  • 16. Coronary Artery Aneurysms in Kawasaki Disease: Risk Factors for Progressive Disease and Adverse Cardiac Events in the US Population.
    Friedman KG, Gauvreau K, Hamaoka-Okamoto A, Tang A, Berry E, Tremoulet AH, Mahavadi VS, Baker A, deFerranti SD, Fulton DR, Burns JC, Newburger JW.
    J Am Heart Assoc; 2016 Sep 15; 5(9):. PubMed ID: 27633390
    [Abstract] [Full Text] [Related]

  • 17. Selective high dose gamma-globulin treatment in Kawasaki disease: assessment of clinical aspects and cost effectiveness.
    Sato N, Sugimura T, Akagi T, Yamakawa R, Hashino K, Eto G, Iemura M, Ishii M, Kato H.
    Pediatr Int; 1999 Feb 15; 41(1):1-7. PubMed ID: 10200128
    [Abstract] [Full Text] [Related]

  • 18. Primary adjunctive corticosteroid therapy is associated with improved outcomes for patients with Kawasaki disease with coronary artery aneurysms at diagnosis.
    Friedman KG, Gauvreau K, Baker A, Son MB, Sundel R, Dionne A, Giorgio T, De Ferranti S, Newburger JW.
    Arch Dis Child; 2021 Mar 15; 106(3):247-252. PubMed ID: 32943389
    [Abstract] [Full Text] [Related]

  • 19. Risk Factors of Coronary Artery Aneurysms in Kawasaki Disease with a Low Risk of Intravenous Immunoglobulin Resistance: An Analysis of Post RAISE.
    Iio K, Morikawa Y, Miyata K, Kaneko T, Misawa M, Yamagishi H, Miura M.
    J Pediatr; 2022 Jan 15; 240():158-163.e4. PubMed ID: 34461064
    [Abstract] [Full Text] [Related]

  • 20. Brain natriuretic peptide as a clinical screening tool for the diagnosis of Kawasaki disease.
    Jung JH, Hwang S, Jung JY, Park JW, Lee EJ, Lee HN, Kim JH, Kim DK, Kwak YH.
    Medicine (Baltimore); 2023 Jul 21; 102(29):e34319. PubMed ID: 37478221
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.